IL-21 Modulates Release of Proinflammatory Cytokines in LPS-Stimulated Macrophages Through Distinct Signaling Pathways

Su-nan Li,Wei Wang,Shou-peng Fu,Jian-fa Wang,Hong-mei Liu,Shan-shan Xie,Bing-run Liu,Yang Li,Qing-kang Lv,Zhi-qiang Li,Wen-jing Xue,Bing-xu Huang,Wei Chen,Ju-xiong Liu
DOI: https://doi.org/10.1155/2013/548073
2013-01-01
Mediators of Inflammation
Abstract:The aim of this study was to investigate the anti-inflammatory effect of IL-21 on LPS-induced mouse peritoneal macrophages. The results showed that IL-21 significantly inhibited LPS-induced mRNA expression of IL-1β, TNF-α, and IL-6 in macrophages, but not of IFN-γ, IL-10, CCL5, or CXCL2. ELISA analysis showed that IL-21 also suppressed LPS-induced production of TNF-αand IL-6 in culture supernatants. Western blot analysis showed that IL-21 clearly inhibited ERK and IκBαphosphorylation and NF-κB translocation in LPS-stimulated macrophages, but it increased STAT3 phosphorylation. Flow cytometric and Western blot analysis showed that IL-21 decreased M1 macrophages surface markers expression of CD86, iNOS, and TLR4 in LPS-stimulated cells. All results suggested that IL-21 decreases IL-6 and TNF-αproduction via inhibiting the phosphorylation of ERK and translocation of NF-κB and promotes a shift from the M1 to M2 macrophage phenotype by decreasing the expression of CD86, iNOS, and TLR4 and by increasing STAT3 phosphorylation in LPS-stimulated cells.
What problem does this paper attempt to address?